We are live on ! Find out more
CA

Calton & Associates Portfolio holdings

AUM $683M
1-Year Est. Return 28.95%
This Fund
S&P 500
This Quarter Est. Return
+7.6%
1 Year Est. Return
+28.95%
3 Year Est. Return
+73.86%
5 Year Est. Return
+79.5%
10 Year Est. Return
AUM
$258M
AUM Growth
+$83.8M
Cap. Flow
+$72.2M
Cap. Flow %
27.93%
Top 10 Hldgs %
22.96%
Holding
291
New
78
Increased
148
Reduced
51
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 6.79%
2 Financials 4.52%
3 Healthcare 3.02%
4 Industrials 2.26%
5 Utilities 2.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MU icon
251
Micron Technology
MU
$966B
$211K 0.08%
+4,217
New +$231K
AMGN icon
252
Amgen
AMGN
$224B
$210K 0.08%
+799
New +$214K
SRPT icon
253
Sarepta Therapeutics
SRPT
$1.88B
$209K 0.08%
+1,614
New +$187K
WM icon
254
Waste Management
WM
$91.2B
$209K 0.08%
1,329
+35
+3% +$5.63K
HZNP
255
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$208K 0.08%
+1,826
New +$152K
RDVY icon
256
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
$207K 0.08%
+4,705
New +$206K
BMY icon
257
Bristol-Myers Squibb
BMY
$130B
$206K 0.08%
+2,865
New +$216K
OEF icon
258
iShares S&P 100 ETF
OEF
$20.4B
$205K 0.08%
+1,200
New +$207K
VBR icon
259
Vanguard Morningstar Small-Cap Value ETF
VBR
$38.1B
$205K 0.08%
+1,288
New +$205K
DE icon
260
Deere & Co
DE
$167B
$202K 0.08%
+471
New +$191K
HPE icon
261
Hewlett Packard
HPE
$71.8B
$187K 0.07%
+11,720
New +$173K
FULT icon
262
Fulton Financial
FULT
$4.64B
$180K 0.07%
10,676
PID icon
263
Invesco International Dividend Achievers ETF
PID
$913M
$178K 0.07%
10,623
+353
+3% +$5.81K
SOFI icon
264
SoFi Technologies
SOFI
$23.2B
$168K 0.06%
36,350
+21,350
+142% +$106K
FOLD
265
DELISTED
Amicus Therapeutics
FOLD
$151K 0.06%
12,387
-40
-0.3% -$450
NEO icon
266
NeoGenomics
NEO
$2.12B
$132K 0.05%
+14,278
New +$133K
TPVG icon
267
TriplePoint Venture Growth BDC
TPVG
$214M
$124K 0.05%
11,900
-696
-6% -$8.42K
OCSL icon
268
Oaktree Specialty Lending
OCSL
$1.12B
$118K 0.05%
5,733
+131
+2% +$2.64K
AVK
269
Advent Convertible and Income Fund
AVK
$569M
$117K 0.05%
11,029
+77
+0.7% +$856
ADPT icon
270
Adaptive Biotechnologies
ADPT
$4.07B
$109K 0.04%
14,285
+3,863
+37% +$30.1K
NSLR
271
Neostellar Capital Corp
NSLR
$284M
$109K 0.04%
+28,610
New +$113K
ALLO icon
272
Allogene Therapeutics
ALLO
$742M
$103K 0.04%
16,314
+4,846
+42% +$44.9K
KMDA icon
273
Kamada
KMDA
$409M
$97.3K 0.04%
24,255
+6,616
+38% +$29.2K
PMM
274
Franklin Managed Municipal Income Trust
PMM
$273M
$85.9K 0.03%
+13,683
New +$83K
CARV
275
DELISTED
Carver Bancorp
CARV
$80.1K 0.03%
19,500
+9,300
+91% +$37.9K

Similar funds

Calton & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Calton & Associates held 291 positions worth $258M, up 48% from $175M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Calton & Associates deployed $72.2M of net new capital in Q4 2022, opening 78 new positions and adding to 148 existing holdings. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 47,642 shares worth $4.36M.

By sector, the portfolio is most concentrated in Technology at 6.8% of assets, down from 7.2% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Utilities ETF, an estimated $2.2M trimmed.

  • Calton & Associates's largest Q4 2022 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 47,642 shares worth $4.36M.
  • Calton & Associates added most to Apple in Q4 2022, an estimated $3.61M increase.
  • Calton & Associates's biggest Q4 2022 reduction was Vanguard Utilities ETF, cutting an estimated $2.2M.
  • Calton & Associates fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $409K.
  • Calton & Associates's ten largest holdings make up 23% of its $258M portfolio in Q4 2022.
  • Calton & Associates opened 78 new positions and closed 8 in Q4 2022.
  • Calton & Associates's portfolio value rose 48% quarter-over-quarter to $258M.

Based on Calton & Associates's 13F filing for Q4 2022, filed 18 Jan 2023.